119 related articles for article (PubMed ID: 7984939)
1. [A new generation of tranquilizing agents].
Escande M; Frexinos M; Fabre S
Rev Prat; 1994 Nov; 44(17):2316-9. PubMed ID: 7984939
[TBL] [Abstract][Full Text] [Related]
2. [New anxiolytic drugs: methodological issues].
Ginestet D; Corruble E
Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of generalized anxiety: new pharmacologic approaches].
Boulenger JP
Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
[TBL] [Abstract][Full Text] [Related]
4. Azapirones: an alternative to benzodiazepines for anxiety.
Cadieux RJ
Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
[TBL] [Abstract][Full Text] [Related]
5. Nonbenzodiazepine anxiolytics: clinical usefulness.
Rickels K
J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):38-44. PubMed ID: 6139368
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic profiles.
Gershon S; Eison AS
J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):45-57. PubMed ID: 6139369
[TBL] [Abstract][Full Text] [Related]
7. On the therapeutic action of alpidem in anxiety disorders: an overview of the European data.
Morselli PL
Pharmacopsychiatry; 1990 May; 23 Suppl 3():129-34. PubMed ID: 1974073
[TBL] [Abstract][Full Text] [Related]
8. New anxiolytics in development.
Mosconi M; Chiamulera C; Recchia G
Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335
[TBL] [Abstract][Full Text] [Related]
9. [Excerpts from the clinical-pharmacologic and clinical studies of Grandaxin].
Szegó J; Somogyi M; Papp E
Acta Pharm Hung; 1993 Mar; 63(2):91-8. PubMed ID: 8100114
[TBL] [Abstract][Full Text] [Related]
10. Treatments for generalized anxiety disorder.
Struzik L; Vermani M; Coonerty-Femiano A; Katzman MA
Expert Rev Neurother; 2004 Mar; 4(2):285-94. PubMed ID: 15853570
[TBL] [Abstract][Full Text] [Related]
11. Buspirone, a novel nonbenzodiazepine anxiolytic.
Kastenholz KV; Crismon ML
Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
[TBL] [Abstract][Full Text] [Related]
12. How to manage anxious patients who are depressed.
Sussman N
J Clin Psychiatry; 1993 May; 54 Suppl():8-16; discussion 17-20. PubMed ID: 8099581
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytics: past, present, and future agents.
Nemeroff CB
J Clin Psychiatry; 2003; 64 Suppl 3():3-6. PubMed ID: 12662127
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology.
Nelson J; Chouinard G
Can J Clin Pharmacol; 1999; 6(2):69-83. PubMed ID: 10519733
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of generalized anxiety disorder.
Davidson JR
J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
[TBL] [Abstract][Full Text] [Related]
16. [Buspirone: a new possibility in the treatment of anxiety].
Faludi G
Orv Hetil; 1994 Aug; 135(33):1807-13. PubMed ID: 8072756
[TBL] [Abstract][Full Text] [Related]
17. Anxioselective anxiolytics: can less be more?
Basile AS; Lippa AS; Skolnick P
Eur J Pharmacol; 2004 Oct; 500(1-3):441-51. PubMed ID: 15464051
[TBL] [Abstract][Full Text] [Related]
18. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".
Uhlenhuth EH
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):109-16. PubMed ID: 6130067
[TBL] [Abstract][Full Text] [Related]
19. Serotonin-1A anxiolytics: an overview.
Feighner JP; Boyer WF
Psychopathology; 1989; 22 Suppl 1():21-6. PubMed ID: 2567039
[TBL] [Abstract][Full Text] [Related]
20. [Proper and improper use of benzodiazepines].
Gorwood P; Lejoyeux M
Rev Prat; 1994 Nov; 44(17):2320-3. PubMed ID: 7984940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
